IP Library Granted Patent US 9,205,256
Granted Patent B2
US 9,205,256 · App. 13/396,605 · Granted Dec 8, 2015

Nocipoint therapy: threshold-gated electrical neuro-immuno-stimulation procedure

Inventor: Charles C. Koo (Palo Alto, CA)
A61N1/36021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,205,256
App. No.
13/396,605
Granted
Dec 8, 2015
Kind
B2
Abstract

A method of reducing pain includes first identifying a muscle; then identify a related pair of Nocipoints on the identified muscle; and applying electrical stimulation to the pair If required, the method may further comprise identifying additional pairs of Nocipoints and applying electrical stimulation to them. The stimulation should be from about 1.5 to 3.5 minutes.

Claims (39)

1. A method, comprising:

identifying an organ;

identifying a related Nocipoint on the identified organ;

identifying a second related Nocipoint on the identified organ;

attaching electrodes to the pair of Nocipoints; and

applying electrical stimulation to the pair of Nocipoints, wherein the applying electrical stimulation to the pair of Nocipoints triggers a reaction of a neuro-immuno cascade.

2. The method of claim 1 , wherein the electrical stimulation for each pair of Nocipoints ranges from about 1.5 minutes to about 3.5 minutes.

3. The method of claim 1 , wherein the electrical stimulation for each pair of Nocipoints has a firing minimum threshold of about 10 mV measured subcutaneously at the nerve.

4. The method of claim 1 , wherein the electrical stimulation for each pair of Nocipoints has an maximum action potential of about 60 mV measured subcutaneously at the nerve.

5. The method of claim 1 , wherein the electrical stimulation for each pair of Nocipoints enables a C-fiber nerve response.

6. The method of claim 1 , wherein the electrical stimulation has a square wave or a sine wave pattern.

7. The method of claim 6 , wherein a pulse frequency of the wave is about 20 to about 80 Hz.

8. The method of claim 7 , wherein an operating range of pulse amplitude of the stimulation is about 70 to about 130 V.

9. The method of claim 7 , wherein an operating range of pulse amplitude of the wave is about 130 to about 170 V.

10. The method of claim 6 , wherein the electrical stimulation has a sine wave pattern.

11. The method of claim 6 , wherein a pulse frequency of the square wave is about 9 Hz.

12. The method of claim 11 , wherein an operating range of pulse amplitude of the square wave is about 130 to about 170 V.

13. The method of claim 1 , wherein the Nocipoints include nociceptors of muscular sensory nerves.

14. The method of claim 1 , wherein the applying electrical stimulation comprises a voltage within a range capable of triggering the reaction of the neuro-immuno cascade.

15. A method, comprising:

identifying an organ;

identifying a related Nocipoint on the identified organ;

identifying a second related Nocipoint on the identified organ;

attaching electrodes to the pair of Nocipoints; and

applying electrical stimulation to the pair of Nocipoints, wherein the pair of Nocipoints are located at a muscle fiber.

16. The method of claim 15 , wherein the electrical stimulation for each pair of Nocipoints ranges from about 1.5 minutes to about 3.5 minutes.

17. The method of claim 15 , wherein the electrical stimulation for each pair of Nocipoints has a firing minimum threshold of about 10 mV measured subcutaneously at the nerve.

18. The method of claim 15 , wherein the electrical stimulation for each pair of Nocipoints has an maximum action potential of about 60 mV measured subcutaneously at the nerve.

19. The method of claim 15 , wherein the electrical stimulation for each pair of Nocipoints enables a C-fiber nerve response.

20. The method of claim 15 , wherein the electrical stimulation has a square wave or a sine wave pattern.

21. The method of claim 20 , wherein a pulse frequency of the wave is about 20 to about 80 Hz.

22. The method of claim 21 , wherein an operating range of pulse amplitude of the stimulation is about 70 to about 130 V.

23. The method of claim 21 , wherein an operating range of pulse amplitude of the wave is about 130 to about 170 V.

24. The method of claim 20 , wherein the electrical stimulation has a sine wave pattern.

25. The method of claim 20 , wherein a pulse frequency of the square wave is about 9 Hz.

26. The method of claim 25 , wherein an operating range of pulse amplitude of the square wave is about 130 to about 170 V.

27. The method of claim 15 , wherein the Nocipoints include nociceptors of muscular sensory nerves.

28. The method of claim 15 , wherein the applying electrical stimulation to the pair of Nocipoints triggers a reaction of a neuro-immuno cascade.

29. The method of claim 28 , wherein the applying electrical stimulation comprises a voltage within a range capable of triggering the reaction of the neuro-immuno cascade.

Continuity (2)
Provisional Application 61443258 · Feb 16, 2011
Related Publication 20120209348A1 · Aug 16, 2012